Mustafa Nazıroğlu | Cellular Neuroscience | Neuroscience Research Excellence Award

Published on by Neuroscientists

Prof. Mustafa Nazıroğlu | Cellular Neuroscience | Neuroscience Research Excellence Award

Prof. Mustafa Nazıroğlu,  Suleyman Demirel University, Turkey.

Professor Mustafa Nazıroğlu is a distinguished scholar with dual doctorates in Physiology and Neuroscience. Beginning his academic journey at Fırat University and advancing to leadership roles at Süleyman Demirel University, he has become a global authority in the fields of oxidative stress, calcium signaling, and TRP ion channels. His research portfolio includes over 270 peer-reviewed articles and thousands of citations, showcasing a profound impact on cellular neuroscience. Beyond research, he has led major international congresses, served on editorial boards of top journals, and has been honored with numerous awards and fellowships in Europe, Asia, and North America.

Profile

Orcid

 

🎓 Early Academic Pursuits

Professor Mustafa Nazıroğlu embarked on his academic journey with a degree from the Faculty of Veterinary Medicine at Fırat University in 1991. Driven by a profound curiosity for physiological mechanisms, he pursued a Ph.D. in Physiology at the same institution, which he completed between 1992 and 1996. His academic ambitions later led him to earn a second Ph.D. in Neuroscience from Süleyman Demirel University (SDU) in 2018, reflecting his commitment to interdisciplinary scholarship and continuous learning.

🧠 Professional Endeavors in Neuroscience and Biophysics

Currently, Professor Nazıroğlu holds the position of Head of the Department of Biophysics and Neuroscience at SDU Medical Faculty. His professional path has been shaped by a deep dedication to academic leadership, having served in several key roles including department head, director of the Neuroscience Research Centre (NOROBAM), and chair of numerous international scientific congresses. Notably, he has successfully organized the biennial International World Congress of Oxidative Stress, Calcium Signalling and TRP Channels from 2006 to 2020, as well as the International Brain Research School series from 2015 to 2024. His influence has also reached global platforms, including service on the organizing committee for the TEMA-14 Congress in Hubei, China, in 2011.

🔬 Contributions and Research Focus

A prolific researcher, Professor Nazıroğlu has significantly advanced our understanding of oxidative stress, calcium signaling, apoptosis, and ion channel (TRP) physiology. His scientific output includes 274 international research articles, 19 review papers, and six book chapters, collectively amassing over 11,500 citations and earning him a Scopus h-index of 59. He has also contributed as an editorial and reviewing member for leading journals such as Biological Trace Element Research, Scientific Reports (Nature Publishing), Frontiers in Physiology, and Current Neuropharmacology, among others. His research has bridged cellular neuroscience with therapeutic strategies, making him a vital contributor to the global scientific discourse.

🏅 Accolades and Recognition

Throughout his career, Professor Nazıroğlu has received numerous national and international honors, celebrating his scientific achievements and global engagement. These include the NATO Research Fellowship (Germany), the Alexander von Humboldt Fellowship (Germany), and the Young Investigative Scientist Award (USA). He has also been recognized by the Turkish Scientific and Technological Research Council (TÜBİTAK), the Howard Hughes Medical Institute (USA), and was the recipient of the prestigious Khwarizmi International Award (Iran). His visiting professorships at institutions in the UK, Qatar, and Japan further underscore his international reputation and collaboration.

🌍 Impact and Influence

Professor Nazıroğlu’s impact extends beyond academic publishing and conference organization. As a mentor, speaker, and panel member, he has shaped the careers of young neuroscientists and fostered a collaborative global network of researchers in calcium signaling and oxidative biology. His participation in expert advisory boards and scientific panels illustrates the depth of his influence on both research policy and biomedical innovation.

📘 Legacy of Knowledge

With over three decades dedicated to science and education, Professor Nazıroğlu has built a lasting legacy grounded in scientific rigor and visionary leadership. His conferences and educational programs, especially the International Brain Research School, have become cornerstone events for knowledge exchange in neuroscience. He has laid a strong foundation for future advancements in TRP channel research and neurophysiology.

🚀 Future Contributions and Vision

Looking forward, Professor Nazıroğlu continues to guide critical research on cellular responses to oxidative stress and ion channel modulation. His forward-thinking approach, combined with an inclusive scientific philosophy, ensures that he remains a leading voice in shaping the next era of biomedical research. With ongoing collaborative projects and mentorship of emerging scholars, his work is poised to influence both clinical and theoretical frontiers for years to come.

Publication

 

  • Title: Vitamin D Supplementation Modulates Blood and Tissue Zinc, Liver Glutathione and Blood Biochemical Parameters in Diabetic Rats on a Zinc-Deficient Diet
    Authors: Kechrid, Z.; Hamdiken, M.; Nazıroğlu, M.; Flores-Arce, M.
    Year: 2023

 

  • Title: Low molecular weight heparin treatment reduced apoptosis and oxidative cytotoxicity in the thrombocytes of patients with recurrent pregnancy loss and thrombophilia: Involvements of TRPM2 and TRPV1 channels
    Authors: Dal, Y.; Nazıroğlu, M.; Özkaya, M.O.
    Year: 2023

 

  • Title: NMDA Receptor Activation Stimulates Hypoxia-Induced TRPM2 Channel Activation, Mitochondrial Oxidative Stress, and Apoptosis in Neuronal Cell Line: Modular Role of Memantine
    Authors: Kenan Yıldızhan; Mustafa Nazıroğlu
    Year: 2023

 

  • Title: Honey bee venom melittin increases the oxidant activity of cisplatin and kills human glioblastoma cells by stimulating the TRPM2 channel
    Authors: Kemal Ertilav; Mustafa Nazıroğlu
    Year: 2023

 

  • Title: Silver nanoparticles potentiate antitumor and oxidant actions of cisplatin via the stimulation of TRPM2 channel in glioblastoma tumor cells
    Authors: Yener Akyuva; Mustafa Nazıroğlu
    Year: 2023

 

  • Title: A novel antagonist of TRPM2 and TRPV4 channels: Carvacrol
    Author: Nazıroğlu, M.
    Year: 2022

 

  • Title: Amantadine Attenuated Hypoxia-Induced Mitochondrial Oxidative Neurotoxicity, Apoptosis, and Inflammation via the Inhibition of TRPM2 and TRPV4 Channels
    Authors: Öcal, Ö.; Coşar, A.; Nazıroğlu, M.
    Year: 2022

 

  • Title: Eicosapentaenoic acid enhanced apoptotic and oxidant effects of cisplatin via activation of TRPM2 channel in brain tumor cells
    Authors: Öcal, Ö.; Nazıroğlu, M.
    Year: 2022

 

  • Title: Paclitaxel Promotes Oxidative Stress–Mediated Human Laryngeal Squamous Tumor Cell Death through the Stimulation of Calcium and Zinc Signaling Pathways: No Synergic Action of Melatonin
    Authors: Kumbul, Y.Ç.; Nazıroğlu, M.
    Year: 2022

 

  • Title: Protective role of selenium on MPP⁺ and homocysteine-induced TRPM2 channel activation in SH-SY5Y cells
    Authors: Yıldızhan, K.; Nazıroğlu, M.
    Year: 2022

 

🧾 Conclusion

Through an outstanding blend of academic excellence, innovative research, and global collaboration, Professor Nazıroğlu has carved a legacy as a leading figure in neuroscience and biophysics. His efforts in organizing international platforms and mentoring young scientists reflect a career committed to advancing knowledge and fostering global scientific networks. With continued contributions and visionary leadership, he remains a driving force in shaping the future of cellular neurophysiology and therapeutic discovery.

Sukesh Sinha | Neuropharmacology | Lifetime achievement Award

Published on by Neuroscientists

Prof. Dr. Sukesh Sinha | Neuropharmacology | Lifetime achievement Award

Prof. Dr. Sukesh Sinha,  National Institute of Nutrition-ICMR, India.

Dr. Sukesh Narayan Sinha, a seasoned toxicologist and research leader, has dedicated his career to advancing the fields of food safety, drug toxicology, pesticide toxicology, and pharmacology. Starting with a strong academic foundation in chemistry from Bihar University, he honed his expertise further through international training at the University of Helsinki and the CDC in the USA. Rising through the ranks of India’s premier health research institutions under the ICMR, Dr. Sinha’s career spans critical research roles that have directly impacted national health and safety policies. His global collaborations and leadership roles reflect a career built on scientific rigor, public service, and continuous learning.

Profile

Google Scholar

 

🎓 Early Academic Pursuits

Born on January 3rd, 1965, Dr. Sukesh Narayan Sinha’s academic journey began with a profound interest in the field of chemistry. He earned his B.Sc. Honours in Chemistry in 1989, followed by an M.Sc. in Chemistry in 1993, and later a Ph.D. in Chemistry in 1999—all from Bihar University, Muzaffarpur. His pursuit of advanced scientific knowledge extended internationally, where he underwent specialized analytical skill development in toxicology at the University of Helsinki, Finland. These foundational years cemented his passion for chemical and toxicological research, shaping the path for a distinguished career in public health and environmental safety.

🧪 Professional Endeavors in Toxicology

Dr. Sinha’s career has been marked by continuous progression through India’s foremost medical and research institutions under the Indian Council of Medical Research (ICMR). Beginning as a Research Fellow at the National Institute of Malaria Research, he moved into industry as a Research Scientist at Alkame Laboratory. His return to the ICMR system in 2001 marked the beginning of a steady ascent through scientific ranks—from Scientist-B to his current post as Senior Grade Deputy Director (Scientist-F) at the ICMR-National Institute of Nutrition (NIN), Hyderabad. He also held key roles at the ICMR-National Institute of Occupational Health, contributing immensely to occupational and environmental health research.

🧬 Contributions and Research Focus

Specializing in Food Toxicology, Drug Research & Toxicology, Pesticide Toxicology, and Pharmacology, Dr. Sinha has focused on identifying and mitigating chemical risks in food and the environment. His work has had a direct impact on public health safety standards in India. Through advanced analytical techniques and interdisciplinary collaboration, he has played a central role in guiding policy and regulatory frameworks concerning food safety. His expertise has not only contributed to toxicological research but has also enhanced national capacities in monitoring hazardous substances affecting human health.

🌍 Global Collaborations and Scientific Exposure

Dr. Sinha’s vision and research have reached global platforms. Notably, he served as a Visiting Scientist at the University of Cincinnati, USA, where he collaborated with experts in Environmental Health. He also completed two intensive courses on health and safety under the Centers for Disease Control and Prevention (CDC) in Atlanta, USA. These international exposures have enriched his scientific perspective, enabling him to incorporate global best practices into India’s health safety frameworks and toxicology research protocols.

🏅 Accolades and Recognition

Throughout his career, Dr. Sinha has earned recognition for his commitment and excellence in scientific research. While specific awards are not listed, his steady promotion within the ICMR ranks—from Scientist-B to Scientist-F—reflects institutional trust in his capabilities and leadership. His selection as a visiting scientist abroad and participation in elite training programs also underscore his status as a respected voice in toxicology and public health research.

📢 Impact and Influence on Public Health

Through his extensive research and governmental role, Dr. Sinha has contributed to national strategies on food safety and toxic substance regulation. His input influences decisions affecting millions of citizens, especially in areas related to food contaminants, drug residues, and environmental pollutants. He continues to serve as a bridge between laboratory research and real-world applications that safeguard public health in India.

🔬 Legacy and Future Contributions

Dr. Sinha’s legacy lies in his unwavering commitment to science and service. With decades of experience and an expanding portfolio of national and international collaborations, he is poised to continue influencing future research, shaping young scientific minds, and contributing to India’s health security. His role at ICMR-NIN ensures that his insights and leadership will guide public health policies and toxicology advancements for years to come.

Publication

  • Quantification of organophosphate insecticides and herbicides in vegetable samples using the “Quick Easy Cheap Effective Rugged and Safe” (QuEChERS) method and a high …
    SN Sinha, K Vasudev, MVV Rao – 2012

 

  • Distribution of pesticides in different commonly used vegetables from Hyderabad, India
    SN Sinha, MVV Rao, K Vasudev – 2012

 

  • Air pollution from solid fuels.
    SN Sinha, PK Nag – 2011

 

  • Environmental monitoring of benzene and toluene produced in indoor air due to combustion of solid biomass fuels
    SN Sinha, PK Kulkarni, SH Shah, NM Desai, GM Patel, MM Mansuri, … – 2006

 

  • Repeated episodes of endosulfan poisoning
    A Dewan, VK Bhatnagar, ML Mathur, T Chakma, R Kashyap, HG Sadhu, … – 2004

 

  • Effect of dissociation energy on ion formation and sensitivity of an analytical method for determination of chlorpyrifos in human blood, using gas chromatography–mass …
    SN Sinha, R Pal, A Dewan, MM Mansuri, HN Saiyed – 2006

 

  • A novel method for pesticide analysis in refined sugar samples using a gas chromatography–mass spectrometer (GC–MS/MS) and simple solvent extraction method
    SN Sinha, VK Bhatnagar, P Doctor, GS Toteja, NP Agnihotri, RL Kalra – 2011

 

  • A liquid chromatography mass spectrometry-based method to measure organophosphorous insecticide, herbicide and non-organophosphorous pesticide in grape and apple samples
    SN Sinha, MVV Rao, K Vasudev, M Odetokun – 2012

 

  • Quantification of organophosphate insecticides in drinking water in urban areas using lyophilization and high-performance liquid chromatography–electrospray ionization-mass …
    SN Sinha, K Vasudev, MVV Rao, M Odetokun – 2011

 

  • Inhibition of protein glycation by procyanidin‐B2 enriched fraction of cinnamon: delay of diabetic cataract in rats
    P Muthenna, G Raghu, C Akileshwari, SN Sinha, P Suryanarayana, … – 2013

 

🏁 Conclusion

Dr. Sukesh Narayan Sinha stands as a respected figure in India’s scientific community, with an enduring impact on toxicology research and public health safety. His career reflects a seamless integration of deep scientific knowledge, practical application, and international collaboration. As he continues his service at ICMR-NIN, his contributions promise to leave a lasting legacy in strengthening food safety standards, environmental health, and public policy for future generations. Dr. Sinha’s journey inspires commitment to research excellence and exemplifies the profound role of science in safeguarding society.

 

Hao Lai | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Dr. Hao Lai | Clinical Neuroscience | Best Researcher Award

Prof. Dr. Hao Lai, Zhongshan Hospital, Fudan University, China.

Dr. Hao Lai is a distinguished cardiovascular surgeon and researcher, currently serving as Chief Physician at Zhongshan Hospital, Fudan University. With over 20 years of clinical expertise, he specializes in aortic and cardiovascular surgery. His academic achievements include a Ph.D. in Surgery from Fudan University and significant contributions to the study of epigenetic mechanisms in thoracic aortic dissection. As a principal investigator of nationally funded projects and co-author of influential publications, Dr. Lai combines scientific rigor with clinical innovation. He has also played a key role in medical education and device development through industry collaboration.

Profile

Scopus

 

🎓 Early Academic Pursuits

Dr. Hao Lai began his academic journey with a strong foundation in medical sciences, culminating in a Ph.D. in Surgery from the prestigious Fudan University. His early academic pursuits were marked by a deep interest in cardiovascular physiology and surgical intervention, which later matured into a specialized focus on aortic diseases. His time as a doctoral candidate not only equipped him with rigorous scientific training but also ignited his lifelong commitment to solving complex clinical problems through research.

🏥 Professional Endeavors

Currently serving as Chief Physician at Zhongshan Hospital, Fudan University, Dr. Hao Lai has accumulated over two decades of extensive clinical experience in cardiovascular and aortic surgery. His professional trajectory reflects a seamless integration of surgical excellence with academic leadership. At Zhongshan Hospital, a leading institution in China, he has spearheaded several clinical programs aimed at enhancing patient outcomes in cases of thoracic aortic dissection and other high-risk cardiovascular conditions.

🔬 Contributions and Research Focus

Dr. Lai’s research centers around the epigenetic mechanisms underlying thoracic aortic dissection, with a particular focus on histone modification and DNA methylation. He is the Principal Investigator of a major research project funded by the National Natural Science Foundation of China, which explores the role of H3K36me3 histone modification and DNMT3B-mediated gene body methylation in the pathogenesis of aortic dissection. His scientific efforts bridge molecular pathology with clinical implications, offering new perspectives on the diagnosis and treatment of life-threatening vascular disorders.

🏆 Accolades and Recognition

A respected voice in cardiovascular medicine, Dr. Hao Lai has co-authored numerous influential articles in high-impact journals such as Cardiovascular Research and Advanced Science. His h-index of 18, as listed on Scopus, reflects his consistent scholarly output and the wide academic acknowledgment of his work. In addition, his authorship of the textbook Practical Surgery (3rd Edition), published by People’s Medical Publishing House, stands as a testament to his educational contributions to the next generation of Chinese surgeons.

🧪 Impact and Innovation

Dr. Lai’s research has made a tangible impact on the understanding and treatment of aortic diseases. His investigation into the epigenetic regulation of vascular pathology has opened new avenues for targeted therapies. Moreover, his collaboration with MicroPort Endovascular MedTech demonstrates his commitment to translating research findings into real-world applications, particularly in the development and refinement of endovascular surgical devices.

🌍 Influence and Collaboration

Beyond his direct research and surgical contributions, Dr. Lai’s influence extends into collaborative domains, both nationally and internationally. His leadership in high-level research grants, clinical trials, and industrial partnerships positions him as a central figure in the evolving landscape of cardiovascular surgery. His collaborative spirit fosters innovation and promotes cross-disciplinary dialogue, essential in today’s complex medical research environment.

🔮 Legacy and Future Contributions

As Dr. Hao Lai continues his distinguished career, his legacy is being shaped not only by his surgical accomplishments but also by his contributions to medical science. His ongoing projects are likely to further clarify the molecular landscape of aortic diseases and inspire new therapeutic strategies. Looking ahead, Dr. Lai is poised to remain at the forefront of cardiovascular innovation, committed to improving patient care through a synthesis of research, education, and clinical practice.

Publication

 

Title: Prevalence and predictors of left atrial thrombus in patients with rheumatic atrial fibrillation undergoing cardiac surgery: a cross-sectional study
Authors: J. Cui, Y. Zhang, Y. Wang, Q. Ji, C. Wang
Year: 2025


Title: A novel open-vascular single-branched stent graft in total arch repair of type A aortic dissection one-year results of a prospective multicenter randomized controlled study
Authors: J. Gu, W. Zhang, L. Kang, H. Lai, C. Wang
Year: 2025


Title: Fibroblast Activation Protein Acts as a Biomarker for Monitoring ECM Remodeling During Aortic Aneurysm via 68Ga-FAPI-04 PET Imaging
Authors: C. Hu, H. Tan, Y. Zhang, X. Chen, L. Wang
Year: 2025


Title: Mitochondrial NAD+ deficiency in vascular smooth muscle impairs collagen III turnover to trigger thoracic and abdominal aortic aneurysm
Authors: J. Zhang, Y. Tang, S. Zhang, K. Zhu, W. Zhang
Year: 2025


Title: Correcting mitochondrial loss mitigates NOTCH1-related aortopathy in mice
Authors: Y. Tang, J. Zhang, Y. Fang, Y. Xu, W. Zhang
Year: 2025


Title: Exploration of 68Ga-FAPI-04 PET/MR in Chronic Type B Aortic Dissection
Authors: C. Hu, Y. Zhang, S. Qiu, H. Shi, L. Wang
Year: 2025


Title: Effects of postoperative glucocorticoids on mitigation of organ dysfunction in patients with type A aortic dissection: A randomized controlled trial
Authors: M. Luo, J. Luo, X. Xu, G. Tu, Z. Luo
Year: 2024


Title: Therapeutic results of three-dimensional aortic valve anatomic repair for regurgitant bicuspid aortic valve
Authors: J. Li, C. Wang, Z. Zuo, W. Ding, T. Hong
Year: 2024


Title: 68Ga-FAPI-04 Positron Emission Tomography/Magnetic Resonance Imaging for Assessing Ascending Aortic Aneurysm
Authors: C. Hu, H. Tan, Y. Zhang, H. Lai, L. Wang
Year: 2024


Title: Sex-based outcomes after thoracic endovascular aortic repair: A systematic review and meta-analysis
Authors: Y. Zhang, Y. Zhang, Y. Wang, L. Wang, Q. Ji
Year: 2025

✅ Conclusion

Dr. Hao Lai’s career represents a powerful blend of surgical precision, scientific insight, and academic leadership. His work has advanced the understanding of aortic diseases at the molecular level while improving surgical outcomes for patients. As he continues to mentor, innovate, and lead research at the intersection of epigenetics and cardiovascular pathology, Dr. Lai’s contributions are set to leave a lasting legacy in both clinical practice and medical science.

 

 

Clotilde Guidetti | Neuropharmacology | Best Researcher Award

Published on by Neuroscientists

Dr. Clotilde Guidetti | Neuropharmacology | Best Researcher Award

Dr. Clotilde Guidetti, Harvard Medical School, Massachusetts General Hospital, United States.

Clotilde Guidetti is an accomplished early-career physician-scientist specializing in Child and Adolescent Neuropsychiatry. With a classical foundation and medical training from the University of Genoa, she excelled academically, earning multiple merit awards and graduating Summa Cum Laude. She completed her specialized residency at the Catholic University of Rome, further refining her clinical expertise. Clotilde’s research focus lies in neurodevelopmental disorders, behavioral interventions, and psychopharmacology in pediatric populations. She has already demonstrated promise as an independent researcher through competitive grant submissions and award-winning conference presentations. Based in Boston, she is actively shaping a career that bridges clinical care and scientific innovation.

Profile

Scopus

 

🎓 Early Academic Pursuits

Clotilde Guidetti began her academic journey with a deep-rooted passion for understanding the human mind and behavior. She earned her High School Diploma in Classical Studies from the prestigious State High School Andrea D’Oria, an early indication of her strong intellectual curiosity and dedication to learning. This foundation in classical education provided her with a broad humanistic perspective that continues to inform her clinical and research approach. She then pursued her Medical Degree at the University of Genoa, where she graduated Summa Cum Laude in 2020. Her academic record was consistently marked by distinction, earning multiple Academic Merit Awards for clinical excellence during her medical studies.

🧠 Professional Endeavors

Following her graduation, Dr. Guidetti further specialized in the field of Child and Adolescent Neuropsychiatry through a rigorous residency program at the Catholic University of Rome. Completed in November 2024, her residency was also distinguished with Summa Cum Laude honors, reflecting both her clinical acumen and compassionate engagement with young patients. Her professional training combined intensive clinical work with scholarly research, preparing her to address complex neurodevelopmental and psychiatric disorders in children and adolescents.

🔬 Contributions and Research Focus

Dr. Guidetti’s primary research interests lie at the intersection of neurodevelopment, behavioral disorders, and psychopharmacology in pediatric populations. Her clinical insights are deeply enriched by her scientific inquiries, particularly those focused on the early diagnosis and personalized treatment of neuropsychiatric conditions. She has already begun shaping her independent research path, as seen in her recent submission for the Brain & Behavior Research Foundation Young Investigator Grant in January 2025. Her project, currently under review, reflects her growing reputation as an emerging scholar in the domain of pediatric neuropsychiatry.

🏅 Accolades and Recognition

Throughout her academic and clinical journey, Clotilde Guidetti has been the recipient of multiple honors that highlight her outstanding abilities. These include three Academic Merit Awards from the University of Genoa and a prestigious Erasmus Socrates Fellowship in 2017–2018, which broadened her training in an international context. In 2022, she received the Attilio Sabato Award from the Società Italiana di Neuropsicofarmacologia (SINPF) for the best poster presentation—an achievement that not only celebrated her communication skills but also her innovative scientific thinking in neuropsychopharmacology.

🌍 Impact and Influence

Though early in her career, Dr. Guidetti has already begun to leave a meaningful mark on the field of child and adolescent mental health. Her dual focus on clinical excellence and academic inquiry ensures that her work resonates both within medical communities and in the lives of the families she serves. With a practice grounded in empathy and scientific rigor, she exemplifies the new generation of clinician-scientists committed to transforming mental health care for the most vulnerable populations.

🧬 Legacy and Future Contributions

As she looks to the future, Clotilde Guidetti aims to expand her contributions to academic psychiatry through collaborative research, cross-disciplinary studies, and the mentorship of emerging professionals in the field. Her continued involvement in national and international research networks promises to amplify her influence, paving the way for innovative treatments and holistic models of care in pediatric neuropsychiatry. Her vision is firmly centered on early intervention, neurodevelopmental resilience, and the integration of clinical practice with cutting-edge neuroscience.

📚 Academic Footprint

Dr. Guidetti currently resides and practices in Boston, Massachusetts, where she continues to build her clinical and research profile. Her dual base—rooted in Italy and expanding into the United States—places her at the nexus of transatlantic collaboration. With each project and presentation, she further refines her expertise and extends her academic footprint, fostering a dynamic career defined by global engagement, intellectual integrity, and unwavering commitment to child and adolescent mental health.

Publication

  • Title: Antidepressants in the acute treatment of post-traumatic stress disorder in adults: a systematic review and meta-analysis

  • Authors: Guidetti, Clotilde; Feeney, Anna; Hock, Rebecca S.; Fava, Maurizio; Papakostas, George I.

  • Year: 2024

 

📝 Conclusion

Dr. Guidetti embodies the ideal of a compassionate clinician and rigorous academic, poised to make significant contributions to the future of child and adolescent mental health. Her career so far reflects a seamless blend of scholarly excellence, clinical sensitivity, and a drive to push the boundaries of understanding in neuropsychiatry. As she continues to expand her research and collaborative efforts globally, her work promises to influence both scientific discourse and practical approaches in mental health care—building a legacy rooted in evidence, empathy, and innovation.

 

Peng Jun | Cellular Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Peng Jun | Cellular Neuroscience | Best Researcher Award

Prof. Peng Jun, Qilu hospital of Shandong University, China.

Professor Jun Peng is a distinguished leader in hematology, currently serving as Vice President of Qilu Hospital of Shandong University and Director of the Department of Hematology. His research is deeply rooted in the immunological pathogenesis and immune tolerance of primary immune thrombocytopenia (ITP), where he has made significant breakthroughs, including the publication of 14 papers in Blood. With a career supported by prestigious national awards, and leadership in 15 high-level research projects, Professor Peng is also a vital figure in Chinese hematology societies and editorial boards of leading journals. His academic rigor, clinical insight, and mentorship continue to shape the future of hematological science in China and beyond.

Profile

Scopus

🎓 Early Academic Pursuits

Professor Jun Peng embarked on his academic journey with a strong commitment to medicine and hematological sciences. From the outset, he exhibited exceptional academic talent and dedication, leading him to pursue both an M.D. and Ph.D. His early education laid a robust foundation for his future specialization in hematology, particularly in the complex field of immunological disorders. His doctoral work, recognized nationally, foreshadowed the groundbreaking contributions he would later make in immune thrombocytopenia research.

🩺 Professional Endeavors

Currently serving as the Vice President of Qilu Hospital of Shandong University, Professor Peng also holds the roles of Chief Physician, Professor, and Ph.D./M.D. Advisor, in addition to being the Director of the Department of Hematology. His clinical and academic responsibilities are carried out with unwavering diligence, mentoring future medical experts while overseeing high-level clinical operations. As a Distinguished Professor of Shandong University, he is actively engaged in shaping the university’s medical excellence on both national and global stages.

🔬 Contributions and Research Focus

At the heart of Professor Peng’s career is his pioneering work on the immunological pathogenesis and immune tolerance of primary immune thrombocytopenia (ITP). He has made substantial contributions to understanding the autoimmune mechanisms that underlie ITP, one of the most challenging hematologic disorders. His scholarly dedication is evidenced by the publication of 14 papers in Blood, a leading journal in hematology, where he served as corresponding or co-corresponding author. His research, grounded in clinical insight and scientific precision, has contributed new perspectives on immune regulation in hematologic diseases.

🏆 Accolades and Recognition

Professor Peng’s excellence has been recognized with numerous prestigious awards. These include the National Science Fund for Distinguished Young Scholars, which highlights his scientific creativity and impact at a young age. He is also a recipient of the One-Hundred National Outstanding Doctoral Dissertation Award, a testament to the academic rigor of his early research. Additionally, he earned the First Prize of the Natural Science Award for Outstanding Achievements in Scientific Research from the Ministry of Education and the Science and Technology Progress Award, reflecting both his academic brilliance and practical impact in the medical field.

🧪 Impact and Influence

Beyond research publications, Professor Peng has significantly influenced the broader scientific and medical communities. As a principal investigator, he has led fifteen national and ministerial-level research projects, including those funded by the National Natural Science Foundation of China and the 973 Program under the Ministry of Science and Technology. His leadership extends to active roles in national academic societies, including the Thrombosis and Hemostasis Group of the Chinese Society of Hematology and the Professional Committee of Experimental Hematology of the Chinese Society of Pathophysiology. These positions allow him to shape the direction of hematological research and clinical guidelines in China.

📚 Academic Leadership and Editorial Roles

A passionate advocate for knowledge dissemination, Professor Peng is a key editorial board member for several respected journals such as Thrombosis Journal, Thrombosis Research, Journal of Clinical Hematology, and the Chinese Journal of Hematology. Through these roles, he ensures that cutting-edge research in hematology is critically evaluated and shared widely, fostering a culture of scientific excellence and collaboration across the globe.

🌟 Legacy and Future Contributions

Professor Jun Peng’s legacy is being forged not only through his past achievements but also through his continued commitment to the advancement of hematological science. His influence spans clinical innovation, academic mentorship, and scientific discovery. As he continues to push the boundaries of understanding in ITP and immune tolerance, he inspires a new generation of physician-scientists. The impact of his work promises to resonate for years to come, offering hope and healing for patients and propelling China’s medical research onto the world stage.

Publication

  • Title: Autoimmune effector mechanisms associated with a defective immunosuppressive axis in immune thrombocytopenia (ITP)
    Authors: Qizhao Li, Geneviève Marcoux, Yuefen Hu, Jung Peng, John W. Semple
    Year: 2024

 

  • Title: Quantitative detection of macular microvascular abnormalities identified by optical coherence tomography angiography in different hematological diseases
    Authors: Tianzi Jian, Fabao Xu, Guihua Li, Li Zhang, Jung Peng
    Year: 2024

 

  • Title: Nicotinamide enhances Treg differentiation by promoting Foxp3 acetylation in immune thrombocytopenia
    Authors: Ju Li, Cheng Zhang, Yuefen Hu, Qi Feng, Xiang Hu
    Year: 2024

 

  • Title: The effects of complement-independent, autoantibody-induced apoptosis of platelets in immune thrombocytopenia (ITP)
    Authors: Lin Sun, Yichen Zhang, Ping Chen, Jung Peng, Zi Sheng
    Year: 2024

 

  • Title: Post-transplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation: a case report, meta-analysis, and systematic review
    Authors: You Yuan Su, Yafei Yu, Zhenyu Yan, Jung Peng, Xinguang Liu
    Year: 2024

 

  • Title: Ion channel Piezo1 activation aggravates the endothelial dysfunction under a high glucose environment
    Authors: Xiaoyu Zhang, Shaoqiu Leng, Xinyue Liu, Shuwen Wang, Jung Peng
    Year: 2024

 

  • Title: Intelligent dual-modality label-free cell classification with light scattering imaging and Raman spectra measurements
    Authors: Faihaa Mohammed Eltigani, Xiaoyu Zhang, Min Liu, Jung Peng, Xuantao Su
    Year: 2024

 

  • Title: Eltrombopag plus diacerein vs eltrombopag in patients with ITP: a multicenter, randomized, open-label phase 2 trial
    Authors: Lu Sun, Xiaoyang Huang, Juan Wang, Ming Hou, Yu Hou
    Year: 2024

 

  • Title: Risk Factors for Mortality in Critically Ill Patients with Coagulation Abnormalities: A Retrospective Cohort Study
    Authors: Qiuyu Guo, Jung Peng, Tichao Shan, Miao Xu
    Year: 2024

 

  • Title: Platelet-derived TGF-β1 induces functional reprogramming of myeloid-derived suppressor cells in immune thrombocytopenia
    Authors: Lingjun Wang, Haoyi Wang, Mingfang Zhu, Ming Hou, Yu Hou
    Year: 2024

 

✅ Conclusion

Through his pioneering research, unwavering clinical dedication, and impactful academic leadership, Professor Jun Peng stands at the forefront of immuno-hematology. His work not only deepens scientific understanding of ITP but also contributes directly to improved patient outcomes. As he continues to inspire through teaching, research, and innovation, Professor Peng’s legacy is one of excellence, influence, and ongoing transformation in the global hematology community.

 

Handrean Soran | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Handrean Soran | Clinical Neuroscience | Best Researcher Award

Prof. Handrean Soran,  Manchester University NHS Foundation Trust, United Kingdom.

Dr. Handrean Soran is a distinguished British endocrinologist and researcher with expertise in diabetes, endocrinology, and cardiovascular diseases. His academic journey began in Iraq and advanced through the UK, where he earned prestigious medical qualifications, including an MD in Medicine and MSc in Diabetes and Endocrinology. Throughout his career, Dr. Soran has contributed significantly to research on the relationship between diabetes and cardiovascular health, publishing extensively in high-impact journals like The New England Journal of Medicine and Lancet. His work has garnered global recognition, including an H-index of 49 and numerous accolades, solidifying his position as a leader in his field.

Profile

Google Scholar

 

Early Academic Pursuits 📚

Handrean Soran’s academic journey began in the Kurdistan region of Iraq, where he completed his A-levels with an impressive score of 94.5% from Sulemani High School in 1985. His drive for knowledge led him to pursue his MBChB at Al-Mustansyria University in Baghdad, Iraq, graduating in 1990. This foundational education set the stage for a career dedicated to medical research and practice. After completing his medical degree, he pursued further specialized training in the UK, where he earned his MRCP from the Royal College of Physicians in Edinburgh in 1999, and later, an MSc in Diabetes and Endocrinology from the University of Liverpool in 2006. These early academic milestones laid the foundation for his later expertise in endocrinology and diabetes, fields that would define his career.

Professional Endeavors 🏥

Dr. Handrean Soran’s professional journey is marked by a dedication to medicine, particularly in the fields of endocrinology and diabetes. He has held significant roles in prestigious institutions, with his current position in the Department of Diabetes, Endocrinology, and Metabolism at Manchester University Hospitals NHS Foundation Trust. His medical career was further enhanced by his qualifications as a Fellow of the Royal College of Physicians (FRCP) from both Glasgow and Edinburgh. Throughout his career, Dr. Soran has worked on developing innovative approaches in clinical care and research, constantly striving to improve patient outcomes and advancing medical knowledge.

Contributions and Research Focus 🔬

Dr. Soran’s research focus primarily centers on diabetes, endocrinology, and cardiovascular health, specifically the interplay between metabolic disorders and heart disease. His research efforts have been integral to understanding the link between diabetes and cardiovascular risk, with a significant body of work examining the effects of treatments on these interconnected conditions. His contributions have been recognized through multiple high-impact publications in renowned journals such as the New England Journal of Medicine, Lancet, and European Heart Journal. With an H-index of 49 and over 130 citations, Dr. Soran’s work continues to shape the clinical landscape in these areas, driving further advancements in treatment protocols and therapeutic strategies for diabetes and cardiovascular diseases.

Accolades and Recognition 🏆

Dr. Soran’s career has been decorated with numerous accolades, affirming his status as a leader in his field. He achieved the prestigious title of Fellow of the Royal College of Physicians (FRCP) in both Edinburgh and Glasgow, a testament to his clinical expertise and contribution to medical science. His groundbreaking work in diabetes and cardiovascular research has earned him recognition not only from peers but also from major medical institutions. His publications in top-tier journals further highlight his academic prowess, solidifying his position as a key thought leader in the medical and academic communities.

Impact and Influence 🌍

Dr. Handrean Soran’s work extends beyond the realm of research publications; it has made a lasting impact on the clinical management of diabetes and cardiovascular diseases worldwide. His insights have contributed to shaping healthcare policies and clinical practices, particularly in the management of diabetic patients at high cardiovascular risk. Through his collaboration with the Division of Cardiovascular Sciences at the University of Manchester, he has fostered interdisciplinary approaches to solving complex medical challenges, advancing the integration of cardiovascular care with endocrinology. His work has influenced not only academic circles but also clinical practice, providing new directions for patient care.

Legacy and Future Contributions 🌱

As Dr. Soran continues his impactful work, his legacy is one of dedication to improving patient health outcomes and advancing the fields of endocrinology and diabetes. With a deep commitment to teaching and mentorship, Dr. Soran plays a pivotal role in training the next generation of doctors and researchers. His future contributions are poised to further explore the intricate relationship between metabolic disorders and cardiovascular health, addressing the growing global burden of these interconnected diseases. His work will undoubtedly continue to guide both clinical practice and future research in endocrinology, diabetes, and cardiovascular medicine, ensuring his ongoing influence in these critical areas.

Global Recognition and Influence 🌐

Dr. Soran’s influence reaches across borders, as evidenced by his extensive publication record and recognition within the global medical community. His research has not only enriched the scientific literature but also contributed to global health initiatives, particularly in the area of metabolic disorders and cardiovascular diseases. With collaborations spanning multiple continents, Dr. Soran is dedicated to improving health outcomes globally, offering expert insights into the prevention and management of diabetes and heart disease. His role in shaping clinical guidelines and his participation in international research collaborations further amplify his global impact.

Academic and Professional Leadership 🎓

In addition to his research contributions, Dr. Soran’s leadership within academia is profound. He holds multiple academic positions, including his affiliation with the University of Manchester, where he plays an integral role in advancing research within the Division of Cardiovascular Sciences. His leadership extends to mentoring young researchers and clinicians, helping to foster a new generation of experts in endocrinology and diabetes. Dr. Soran’s academic vision continues to drive progress in both education and research, making significant strides in improving how diabetes and cardiovascular diseases are understood and treated. His future work promises to leave a lasting mark on medical education and the advancement of scientific knowledge.

Publication

  • Cardiovascular efficacy and safety of bococizumab in high-risk patients
    Author: PM Ridker
    Year: 2017

 

  • Volanesorsen and triglyceride levels in familial chylomicronemia syndrome
    Author: JL Witztum
    Year: 2019

 

  • Triglyceride lowering with pemafibrate to reduce cardiovascular risk
    Author: A Das Pradhan
    Year: 2022

 

  • Diabetes dyslipidemia
    Author: JD Schofield
    Year: 2016

 

  • Lysosomal acid lipase deficiency–an under-recognized cause of dyslipidaemia and liver dysfunction
    Author: Ž Reiner
    Year: 2014

 

  • Obesity: a critical risk factor in the COVID‐19 pandemic
    Author: S Kwok
    Year: 2020

 

  • Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY …
    Author: KK Ray
    Year: 2019

 

  • Hypercholesterolaemia and its management
    Author: D Bhatnagar
    Year: 2008

 

  • Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies
    Author: B Williams
    Year: 2018

 

  • Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset …
    Author: FJ Raal
    Year: 2017

 

Conclusion

Dr. Handrean Soran’s career is marked by profound contributions to medical science, particularly in the fields of diabetes and cardiovascular health. His groundbreaking research and clinical expertise have had a significant impact on both academic and healthcare practices worldwide. As a recognized leader in his field, Dr. Soran’s work continues to influence the management of metabolic and cardiovascular diseases, and his future contributions promise to further advance these critical areas of medical research and practice. His legacy is one of dedication, leadership, and a commitment to improving health outcomes globally.

 

Wenhui He | Cellular Neuroscience | Innovative Research Award

Published on by Neuroscientists

Mr. Wenhui He | Cellular Neuroscience | Innovative Research Award

Mr. Wenhui He, Army Medical University, China.

Wenhui He is a dedicated lecturer and researcher at the Army Medical University, where she has spent eight years teaching biochemistry and molecular biology. With a strong academic background and deep expertise in neural regulation and cardiovascular diseases, her research delves into complex mechanisms underlying aortic dissection and atherosclerosis. Through her dual roles in education and scientific discovery, she contributes significantly to both student development and the broader medical research community. Her work not only adds to the scientific understanding of cardiovascular pathophysiology but also informs potential therapeutic strategies.

Profile

Scopus

 

🎓 Early Academic Pursuits

Wenhui He embarked on her academic journey with a deep passion for unraveling the complexities of human biology, particularly focusing on the intricate workings of the cardiovascular system. Her early education laid a strong foundation in biochemistry and molecular biology, disciplines that would later become central to her teaching and research. With a commitment to excellence, she pursued advanced studies that equipped her with the scientific rigor and analytical skills necessary for impactful research in biomedical sciences.

🧪 Professional Endeavors

Currently serving as a lecturer at the School of Basic Medical Sciences, Army Medical University, Wenhui He has spent the past eight years educating future medical professionals. She specializes in biochemistry and molecular biology, delivering foundational knowledge with clarity and depth. Her role extends beyond teaching, as she actively contributes to the academic and research community within the university, balancing the dual responsibilities of pedagogy and scientific exploration.

🧬 Contributions and Research Focus

Wenhui He’s research is centered on the neural regulation and molecular mechanisms of cardiovascular diseases, particularly aortic dissection and atherosclerosis. Her work investigates the underlying signaling pathways and neurovascular interactions that drive the onset and progression of these conditions. By integrating neurobiology with vascular pathology, her studies aim to uncover therapeutic targets and improve understanding of disease mechanisms, thus contributing to the development of more effective interventions.

🏅 Accolades and Recognition

Throughout her academic and professional career, Wenhui He has earned the respect of her peers and students alike. While her contributions have been largely rooted in teaching and research, her dedication to academic excellence and her commitment to medical education have not gone unnoticed. Her role as a faculty member at a leading military medical institution speaks to her capabilities and the trust placed in her by the academic community.

🌍 Impact and Influence

Through her dual engagement in teaching and research, Wenhui He has had a meaningful impact on both the scientific community and the future of medicine. Her research contributes valuable knowledge to the fields of cardiovascular science and neurovascular biology, while her teaching helps shape the minds of tomorrow’s medical practitioners. The blend of theoretical insight and practical relevance in her work makes her an influential figure in her domain.

🔬 Legacy and Future Contributions

With a strong foundation in molecular biology and a clear focus on cardiovascular disease mechanisms, Wenhui He is poised to continue contributing groundbreaking research. Her future endeavors aim to bridge the gap between basic medical science and clinical application, ensuring that her work remains both scientifically significant and socially relevant. As she mentors young scientists and expands her research horizons, her legacy is likely to grow in scope and impact.

❤️‍🩹 Commitment to Cardiovascular Health

Wenhui He’s unwavering dedication to understanding and combating cardiovascular diseases reflects her commitment to public health. Her focus on conditions like aortic dissection and atherosclerosis not only addresses some of the leading causes of mortality but also aligns with global efforts to reduce the burden of chronic illnesses. Through education, research, and collaboration, she continues to make strides in protecting and improving heart health.

Publicatio

  • Title: From inflammation to remodelling: A novel BASP1⁺ monocyte subset as a catalyst for acute aortic dissection

  • Authors: Wenhui He, Sanjiu Yu, Jun Li, Wei Cheng, Shuangshuang Dai, et al.

  • Year: 2025

 

🏁 Conclusion

Combining passion, precision, and purpose, Wenhui He exemplifies the modern medical scientist—committed to excellence in teaching and innovation in research. Her journey reflects a meaningful integration of neuroscience, molecular biology, and cardiovascular science. As she continues to push boundaries in her field, her impact will be felt not only through her discoveries but also through the many students and researchers she inspires. Her career stands as a testament to the power of scientific curiosity and educational dedication in shaping a healthier future.

 

Soumya Pahari | Clinical Neuroscience | Young Researcher Award

Published on by Neuroscientists

Dr. Soumya Pahari | Clinical Neuroscience | Young Researcher Award

Dr. Soumya Pahari,  Nepalese Army Institute of Health Sciences, Nepal.

Dr. Soumya Pahari, MBBS, is a globally engaged physician with a deep-rooted passion for neurosurgery, clinical research, and public health advocacy. From excelling in medical school on a full academic scholarship to completing hands-on neurosurgical training in both Nepal and the U.S., Dr. Pahari has built a career that blends clinical excellence with scholarly rigor. Their dedication to global neurosurgical research, reflected through projects with Vanderbilt University and Mission Brain Foundation, demonstrates a commitment to solving complex medical challenges through evidence-based innovation. Beyond the operating theater, their work as a mental health advocate and educator underscores a holistic approach to medicine that prioritizes human connection, education, and equity.

 

Profile

Google Scholar

 

🎓 Early Academic Pursuits

Dr. Soumya Pahari’s academic journey began with a strong foundation in science, nurtured during their high school years at St. Xavier’s College, Nepal,  Their passion for medicine soon led them to pursue an MBBS degree at the Nepalese Army Institute of Health Sciences (NAIHS), where they not only excelled academically but also earned the prestigious NAIHS Academic Scholarship in 2016. Throughout medical school, they developed a keen interest in neuroscience and surgical disciplines, which laid the groundwork for their future specialization in neurosurgery and global neurosurgical initiatives.

🧠 Professional Endeavors in Neurosurgery

Driven by an unrelenting commitment to clinical excellence, Dr. Pahari’s professional training includes a year-long position as House Officer in the Department of Neurosurgery at Shree Birendra Hospital, Nepal’s only neurosurgical unit under the Nepalese Army. Here, they performed critical procedures such as EVD insertion, burr hole evacuation, and tracheostomy, while actively assisting in advanced surgeries like aneurysm clipping and tumor resections. Later, as a Visiting Scholar in Neurosurgery at West Virginia University (WV, USA) under Dr. P. David Adelson, they broadened their exposure by shadowing surgeons, presenting clinical cases, and initiating a quality improvement project focused on vagal nerve stimulators for refractory epilepsy patients. These experiences have collectively enriched Dr. Pahari’s surgical acumen and global neurosurgical insight.

🔬 Contributions and Research Focus

Research forms a core pillar of Dr. Pahari’s career, with a focus on pediatric cerebrovascular disorders, endovascular interventions in extradural hematomas, and quality improvement in epilepsy care. As a Research Collaborator with Vanderbilt Global Neurosurgery Program, they are leading a systematic review to assess the global burden of pediatric cerebrovascular diseases, contributing meaningfully to evidence-based global neurosurgical strategies. Simultaneously, their work with the Mission Brain Foundation aims to analyze the emerging utility of endovascular techniques in traumatic brain injury management. Earlier, they also contributed as an administrator and content developer at the Abdulrauf University of Neurosurgery’s Research Institute in California, helping curate educational content for aspiring neurosurgeon-scientists.

🌍 Advocacy, Mental Health & Global Impact

Dr. Pahari’s commitment to health extends beyond the operating room into the domain of mental health and psychosocial well-being. As a Founding Board Member of Antardhoni Nepal, they’ve played a vital role in promoting mental health awareness and support services in underserved communities. Their leadership also reflects through media engagement as a Podcast Host for ‘Behind White Coats’, a platform where pressing global health issues and common illnesses are discussed with clarity and compassion. These endeavors underline their belief in a holistic approach to health, where mental, social, and physical well-being are equally prioritized.

🏆 Accolades and Recognition

Throughout their academic and professional career, Dr. Pahari has garnered several accolades, notably being ECFMG Certified in August 2024 and scoring an impressive 253 on USMLE Step 2. Their achievements are further supported by certifications such as the Diploma in Neurotrauma Care from the Global Neuro Foundation, which granted them 43.5 AMA PRA Category 1 credits, enhancing their preparedness for managing acute neurotrauma in global contexts. These recognitions reflect their unwavering commitment to clinical excellence and continuous learning.

📢 Influence Through Education and Media

An inspiring communicator and educator, Dr. Pahari has invested time in peer tutoring through Medlife Stories, where they guided junior students through complex medical concepts. Their innovative spirit also led them to head marketing strategies for The SET Exhibition during their early college years—an event that showcased student innovation in science and technology. Through educational content creation, public speaking, and mentoring, Dr. Pahari continues to shape the next generation of healthcare leaders while making medicine more accessible and engaging for all.

🚀 Legacy and Future Contributions

As Dr. Soumya Pahari looks ahead, their vision is clearly anchored in the intersection of clinical neurosurgery, global health equity, and academic research. With ongoing collaborations in global neurosurgical research and growing experience in both developed and developing healthcare systems, they are uniquely positioned to bridge disparities in neurosurgical care. Their future contributions are expected to amplify the voices of underrepresented populations in global health discourse, enhance neurosurgical systems through data-driven quality improvement, and inspire young physicians to approach medicine with both empathy and rigor. Their legacy, still unfolding, promises to be one of profound impact, innovation, and inclusion.

Publication

 

  • Title: Gallstone among patients presenting to the department of surgery in a tertiary care center: a descriptive cross-sectional study
    Authors: S Pahari, S Basukala, U Piya, Y Khand, B Thapa, O Thapa, S Thapa
    Year: 2023

 

  • Title: A rare case of retroperitoneal extension in Fournier’s gangrene: A case report and review of literature
    Authors: S Basukala, Y Khand, S Pahari, KB Shah, A Shah
    Year: 2022

 

  • Title: Large posterior mediastinal ganglioneuroma with intradural cervical spine extension: a rare case report and review of literature
    Authors: A Dahal, JJ Malla, D Neupane, N Lageju, LS Jaiswal, S Chaudhary, …
    Year: 2022

 

  • Title: Complicated pylephlebitis secondary to perforated appendicitis in a child-A rare case report
    Authors: S Pahari, M Shrestha, S Basukala, P Kafle, K Rai, Y Khand, O Thapa, …
    Year: 2022

 

  • Title: A life-threatening complication of biliary peritonitis following T-tube removal: A case report and review of literature
    Authors: Y Khand, S Basukala, U Piya, P Mainali, S Pahari, KB Shah
    Year: 2022

 

  • Title: Spontaneous splenic hematoma secondary to dengue infection: a rare case report
    Authors: S Pahari, S Basukala, P Kunwar, K Thapa, Y Khand, O Thapa
    Year: 2023

 

  • Title: An unusual case of perforated stump appendicitis: a case report
    Authors: S Basukala, BD Pathak, S Pahari, S Gurung, B Basukala, BB Rayamajhi, …
    Year: 2022

 

  • Title: Acute Pancreatitis among Patients Visiting the Department of Surgery in a Tertiary Care Centre: A Descriptive Cross-sectional Study
    Authors: S Basukala, BD Pathak, P Dawadi, S Bohara, A Tamang, S Pahari, …
    Year: 2023

 

  • Title: Patient Safety and organizational Safety Culture in Surgery: A Need of an Hour in the developing countries
    Authors: S Basukala, S Bohara, A Thapa, A Shah, S Pahari, Y Khand, O Thapa, …
    Year: 2022

 

  • Title: Acute recurrent pancreatitis in a child with pancreatic divisum–A case report
    Authors: O Thapa, S Basukala, M Shrestha, Y Khand, S Pahari, S Bohara, A Thapa, …
    Year: 2022

 

✅ Conclusion

With a powerful blend of academic distinction, surgical skill, and compassionate advocacy, Dr. Soumya Pahari stands at the forefront of a new generation of physician-leaders. Their journey is a testament to the impact that global collaboration, research, and empathy can have on healthcare. As they continue to pursue excellence in neurosurgery and global health, their work promises not only to improve lives in the operating room but to inspire systemic change across borders. The future undoubtedly holds even greater contributions from this rising medical changemaker.

Camilla Bellone | Translational Neuroscience | Best Researcher Award

Published on by Neuroscientists

Assoc. Prof. Dr. Camilla Bellone | Translational Neuroscience | Best Researcher Award

Assoc. Prof. Dr. Camilla Bellone,  University of Geneva, Switzerland.

Dr. Camilla Bellone is a renowned neuroscientist whose academic and research career has been marked by excellence, innovation, and impact. From her foundational training in Italy to her leadership role in Geneva, she has made pioneering contributions to understanding the neural underpinnings of social behavior. Her work bridges basic science and clinical relevance, and she has played a vital role in training, mentorship, and international collaboration within the neuroscience community.

Profile

Google Scholar

 

🎓 Early Academic Pursuits

Dr. Camilla Bellone began her academic journey with a Master’s degree in Pharmacy from the University of Milano in 2000. With a strong foundation in pharmacology and medical chemistry, she pursued her Ph.D. in “Pharmacology, Toxicology, and Medical Chemotherapy” at the same institution, completing it in 2006. Her early education shaped a robust scientific mindset, preparing her for a career at the intersection of neuroscience and pharmacology. These formative years set the tone for her later work on the molecular mechanisms that govern complex behaviors in both healthy and diseased states.

🧪 Professional Endeavors

After her doctoral studies, Dr. Bellone enhanced her research acumen through a postdoctoral fellowship at the University of California, San Francisco (UCSF), gaining international exposure. She later returned to Switzerland, where she served as a scientist under the Ambizione Fellowship at the University of Geneva. Her academic path took a significant leap when she became an Assistant Professor at the University of Lausanne in 2014, followed by a transition to the University of Geneva in 2016. In 2020, she was promoted to Associate Professor in the Department of Basic Neuroscience, where she continues to lead cutting-edge investigations and mentor future neuroscientists.

🧠 Contributions and Research Focus

At the core of Dr. Bellone’s research lies a deep interest in the neurobiological basis of social behavior, with a particular focus on how these processes are disrupted in neuropsychiatric disorders. Her lab explores the synaptic and circuit-level mechanisms that underpin social cognition, often using advanced molecular and behavioral techniques. Her work has provided critical insights into how alterations in neural plasticity and connectivity contribute to diseases such as schizophrenia and autism spectrum disorders. With over 40 peer-reviewed publications in high-impact journals like Nature Neuroscience and Neuron, Dr. Bellone’s research continues to advance the field of behavioral neuroscience.

🏆 Accolades and Recognition

Dr. Bellone’s scientific excellence has been recognized through several prestigious honors. In 2023, she received the EBBS Mid-Career Award and the Leenaards Scientific Prize for her collaborative project on cerebellar stimulation in schizophrenia. Earlier, she was elected to the distinguished FENS-KAVLI Network of Excellence in 2015, highlighting her position among Europe’s most promising neuroscientists. In 2014, she was honored with the Fondation du Prix Pfizer de la Recherche, marking an early milestone in her independent research career.

🌍 Impact and Influence

Beyond her lab, Dr. Bellone has made meaningful contributions to the academic and scientific community. She has delivered over 20 invited lectures at international conferences and institutions, sharing her discoveries with a global audience. As a dedicated mentor, she has guided eight master’s students and seven PhD candidates, nurturing the next generation of neuroscientists. Her commitment extends to active service on academic committees, grant review panels, and editorial boards, reflecting her role as a respected leader in the field.

👩‍🔬 Balancing Science and Life

A champion of work-life integration, Dr. Bellone has managed to thrive professionally while embracing motherhood. She took two career breaks following the birth of her three children, exemplifying resilience and balance in a demanding academic landscape. Her story is an inspiration to young scientists, especially women, striving to build careers in STEM while honoring personal life choices.

🔬 Legacy and Future Contributions

Looking ahead, Dr. Bellone’s work holds promise for transforming our understanding of social dysfunction in mental illness. Her innovative approaches—blending circuit neuroscience, pharmacology, and behavior—position her as a leading voice in the neurobiology of social behavior. With continued support from initiatives like the ERC Consolidator Grant, her research will likely pave the way for novel therapeutic interventions, leaving a lasting legacy in neuroscience and psychiatry.

Publication

  • Title: NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease
    Author: P Paoletti, C Bellone, Q Zhou
    Year: 2013

 

  • Title: Cocaine triggered AMPA receptor redistribution is reversed in vivo by mGluR-dependent long-term depression
    Author: C Bellone, C Lüscher
    Year: 2006

 

  • Title: Rapid bidirectional switching of synaptic NMDA receptors
    Author: C Bellone, RA Nicoll
    Year: 2007

 

  • Title: Cocaine inverts rules for synaptic plasticity of glutamate transmission in the ventral tegmental area
    Author: M Mameli, C Bellone, MTC Brown, C Lüscher
    Year: 2011

 

  • Title: In vivo reprogramming of circuit connectivity in postmitotic neocortical neurons
    Author: A De la Rossa, C Bellone, B Golding, I Vitali, J Moss, N Toni, C Lüscher, …
    Year: 2013

 

  • Title: Mechanisms of synaptic depression triggered by metabotropic glutamate receptors
    Author: C Bellone, C Lüscher, M Mameli
    Year: 2008

 

  • Title: Effects of streptozotocin‐diabetes on the hippocampal NMDA receptor complex in rats
    Author: F Gardoni, A Kamal, C Bellone, GJ Biessels, GMJ Ramakers, F Cattabeni, …
    Year: 2002

 

  • Title: Neurons under T cell attack coordinate phagocyte-mediated synaptic stripping
    Author: G Di Liberto, S Pantelyushin, M Kreutzfeldt, N Page, S Musardo, R Coras, …
    Year: 2018

 

  • Title: mGluRs induce a long‐term depression in the ventral tegmental area that involves a switch of the subunit composition of AMPA receptors
    Author: C Bellone, C Lüscher
    Year: 2005

 

  • Title: SHANK3 controls maturation of social reward circuits in the VTA
    Author: S Bariselli, S Tzanoulinou, C Glangetas, C Prévost-Solié, L Pucci, …
    Year: 2016

 

✅ Conclusion

Dr. Bellone’s journey reflects a remarkable blend of scientific curiosity, academic leadership, and personal resilience. As she continues to explore the brain’s most intricate social circuits, her influence will undoubtedly expand across neuroscience, psychiatry, and therapeutic innovation. Her career serves as both a roadmap and an inspiration for emerging scientists navigating the evolving landscape of brain research.

 

Ketan Bulsara | Cellular Neuroscience | Excellence in Neuroscience Research Award

Published on by Neuroscientists

Dr. Ketan Bulsara | Cellular Neuroscience | Excellence in Neuroscience Research Award

Dr. Ketan Bulsara, University of Connecticut, United States.

Dr. Ketan Ramanlal Bulsara is a distinguished neurosurgeon, educator, and administrator whose career has been defined by excellence in academic leadership, innovative research, and patient-centered surgical advancements. With a strong foundation in medical education and training, he has held prestigious positions at leading institutions, making significant contributions to the fields of cerebrovascular and skull base surgery. His work in neurosurgical education, healthcare policy, and perioperative quality improvement continues to influence the next generation of medical professionals.

Profile

Google Scholar

 

🎓 Early Academic Pursuits: The Foundation of Excellence

Dr. Ketan Ramanlal Bulsara’s journey into the world of neurosurgery began with a strong academic foundation. He earned his Bachelor of Science in Biology and Neuroscience, graduating Magna Cum Laude from Davidson College in 1992. His passion for medicine led him to Duke University School of Medicine, where he earned his Medical Degree with Honors in 1996. Committed to mastering his craft, Dr. Bulsara underwent rigorous neurosurgical training at Duke University Medical Center, progressing through internship, residency, and chief residency roles. His dedication to specialized knowledge took him to the University of Iowa for a fellowship in Transoral Surgery and later to Duke’s Neurovascular Program for an advanced Endovascular Fellowship, earning CAST certification by the Senior Neurological Society.

🎉 Professional Endeavors: Pioneering Neurosurgical Excellence

Dr. Bulsara has held esteemed academic and leadership positions throughout his career. Beginning as an Assistant Professor at the University of Missouri, he quickly ascended to directorship roles at Yale University, where he led Neuroendovascular and Skull Base Surgery Programs. His expertise and leadership took him to UConn Health, where he has served as Professor and Chief of Neurosurgery since 2017. As Program Director of UConn’s Neurosurgery Residency Training Program and Director of Operating Room Quality, he has been instrumental in shaping the next generation of neurosurgeons. His administrative impact extended further when he was appointed Interim Inaugural Chairman of UConn’s Department of Neurosurgery in 2024.

📚 Contributions and Research Focus: Advancing Neurosurgical Innovation

Throughout his career, Dr. Bulsara has been at the forefront of neurosurgical research, focusing on cerebrovascular and skull base surgery, neuroendovascular techniques, and perioperative advancements. His tenure at Yale and UConn Health has been marked by groundbreaking contributions to neurosurgical methodologies, patient safety protocols, and cutting-edge surgical interventions. With a keen interest in medical policy and administration, he also serves as Chair of the UConn Health/University of Connecticut Dean’s Task Force on Coding and Documentation, ensuring optimal standards in medical practice.

🏆 Accolades and Recognition: A Trailblazer’s Achievements

Dr. Bulsara’s exemplary work has earned him widespread recognition in academic, clinical, and administrative spheres. His leadership has been pivotal in strengthening neurosurgical departments and residency programs, earning respect from peers and students alike. His continued commitment to excellence led him to pursue an Executive MBA at Yale School of Management, which he completed in 2017, equipping him with advanced skills in healthcare management and strategic planning. Furthering his multidisciplinary expertise, he embarked on a legal education at the University of Connecticut School of Law in 2024, highlighting his commitment to integrating medicine, business, and law for the betterment of healthcare.

💡 Impact and Influence: Shaping the Future of Neurosurgery

Dr. Bulsara’s influence extends far beyond the operating room. As a mentor, he has trained and guided numerous neurosurgeons, instilling in them the values of precision, innovation, and patient-centered care. His research and administrative contributions have shaped hospital policies and perioperative strategies, leading to improved surgical outcomes and enhanced healthcare delivery systems. His work in academic leadership continues to bridge the gap between medical practice, research, and education.

 

Publication

  • Spinal axon regeneration evoked by replacing two growth cone proteins in adult neurons – HM Bomze, KR Bulsara, BJ Iskandar, P Caroni, JH Pate Skene (2001)

 

  • Longitudinal molecular trajectories of diffuse glioma in adults – FP Barthel, KC Johnson, FS Varn, AD Moskalik, G Tanner, E Kocakavuk, et al. (2019)

 

  • Glioma progression is shaped by genetic evolution and microenvironment interactions – FS Varn, KC Johnson, J Martinek, JT Huse, MLP Nasrallah, P Wesseling, et al. (2022)

 

  • Accuracy of prediction instruments for diagnosing large vessel occlusion in individuals with suspected stroke: a systematic review for the 2018 guidelines for the early… – EE Smith, DM Kent, KR Bulsara, LY Leung, JH Lichtman, MJ Reeves, et al. (2018)

 

  • Perioperative complications in transforaminal lumbar interbody fusion versus anterior–posterior reconstruction for lumbar disc degeneration and instability – AT Villavicencio, S Burneikiene, KR Bulsara, JJ Thramann (2006)

 

  • Vessel wall magnetic resonance imaging identifies the site of rupture in patients with multiple intracranial aneurysms: proof of principle – CC Matouk, DM Mandell, M Günel, KR Bulsara, A Malhotra, R Hebert, et al. (2013)

 

  • Safety of transforaminal lumbar interbody fusion and intervertebral recombinant human bone morphogenetic protein—2 – AT Villavicencio, S Burneikiene, EL Nelson, KR Bulsara, M Favors, et al. (2005)

 

  • Laminectomy versus percutaneous electrode placement for spinal cord stimulation – AT Villavicencio, JC Leveque, L Rubin, K Bulsara, JP Gorecki (2000)

 

  • Indications for thrombectomy in acute ischemic stroke from emergent large vessel occlusion (ELVO): report of the SNIS Standards and Guidelines Committee – M Mokin, SA Ansari, RA McTaggart, KR Bulsara, M Goyal, M Chen, et al. (2019)

 

  • Review of the literature on de novo formation of cavernous malformations of the central nervous system after radiation therapy – SM Nimjee, CJ Powers, KR Bulsara (2006)

 

💪 Conclusion

A visionary in neurosurgery, Dr. Bulsara’s impact transcends surgical practice, reaching into medical education, research, and healthcare administration. His multidisciplinary approach—combining medicine, business, and law—positions him as a leader in shaping the future of healthcare. His commitment to innovation and excellence ensures that his contributions will continue to elevate neurosurgical standards and inspire future generations of medical professionals.